Consequences of long-term discontinuation of vascular endothelial growth factor inhibitor therapy in the patients with neovascular age-related macular degeneration

Acta Ophthalmol. 2014 Dec;92(8):e697-8. doi: 10.1111/aos.12417. Epub 2014 Apr 20.
No abstract available

Publication types

  • Letter
  • Observational Study

MeSH terms

  • Aged
  • Aged, 80 and over
  • Angiogenesis Inhibitors / therapeutic use*
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Bevacizumab
  • Female
  • Humans
  • Male
  • Middle Aged
  • Ranibizumab
  • Recurrence
  • Retrospective Studies
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors*
  • Wet Macular Degeneration / diagnosis*
  • Wet Macular Degeneration / drug therapy*
  • Withholding Treatment*

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal, Humanized
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Bevacizumab
  • Ranibizumab